Sanofi-GSK Covid vax shows strong immune responses in Phase 2 trial
Sanofi-GSK Covid vax shows strong immune responses in Phase 2 trial By IANS | 0 Views Sanofi-GSK Covid vax shows strong immune responses in Phase 2 trial. Image Source: IANS News Paris, May 18 : A Covid-19 vaccine developed by pharmaceutical giants Sanofi and Glaxo Smith Kline (GSK) has shown strong rates of neutralising antibody responses against the infectious Coronavirus disease in the Phase-II trial. The Phase-II trial, which involved 722 adult volunteers from the US and Honduras between 18 to 95 years old, did not raise any safety concerns and also produced a strong immune resp...